Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Andrew Spaventa Insider Profile

4 Followers

Andrew Spaventa, CEO, Director at Singular Genomics Systems, holds 308.08K shares in Aspen Neuroscience, Inc. (Ticker: ASPE), holds 0.00 shares in Singular Genomics Systems (Ticker: OMIC).

Andrew Spaventa's Trading History

ASPEAspen Neuroscience, Inc.		Nov 02, 2026DirectorUninformative Buy―$3.79M
OMICSingular Genomics Systems		Feb 25, 2025―Uninformative Sell―$0.00
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Andrew Spaventa insider profile FAQ

What is the percentage of profitable transactions made by Andrew Spaventa?
The percentage of profitable transactions made by Andrew Spaventa is 50%.
What is the average return per transaction made by Andrew Spaventa?
The average return per transaction made by Andrew Spaventa is -5.90%.
What stocks does Andrew Spaventa hold?
Andrew Spaventa holds: OMIC, ASPE stocks.
What was Andrew Spaventa's most profitable transaction?
Andrew Spaventa’s most profitable transaction was an Informative Buy of OMIC stock on November 20, 2023. The return on the trade was 78.20%.
What is Andrew Spaventa's role in Singular Genomics Systems?
Andrew Spaventa's role in Singular Genomics Systems is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.